Jens Grueger

Jens Grueger is Head of Global Access at F. Hoffmann-La Roche, based in Basel, Switzerland. He and his team drive holistic access strategies across our organization to ensure that Roche and healthcare systems deliver rapid, broad and sustainable patient access to our innovative offerings. Prior to this Jens was Head of Global Market Access Primary Care at Pfizer, based in New York and London (2009-2011), Head of Global Pricing & Health Economics at Novartis Pharma in Basel, Switzerland (1999-2009) and Director of Health Economics at the German affiliate of SmithKline Beecham Pharma in Munich (1994-1997). He founded Diversified Health Systems, a start-up company providing internet based disease management services to physician networks in Europe (1997-1999). He started his professional career in 1986 as a Senior Consultant with Dornier Systems GmbH, Friedrichshafen, Germany, where he directed health care services research and consulting projects for national and regional government agencies in Germany, Austria and Switzerland. Jens holds a master degree (Diplom) in Medical Statistics and Theoretical Medicine, and a PhD in mathematical statistics from the Technical University of Dortmund, Germany. He lectured on epidemiology, stochastic processes and mathematical statistics, and has >40 publications in biometrics, cancer epidemiology, and health economics. From 2004-2006, Jens was a Director of the International Society for Pharmacoeconomics and Outcomes Research.